Table 4 Pharmacologic treatment
Variable | Multidisciplinary Program | Personalized Care | Between groups | |||||
|---|---|---|---|---|---|---|---|---|
Baseline | 6 Months | p-value | Baseline | 6 Months | p-value | Baseline | 6 Months | |
n = 128 | n = 113 | n = 128 | n = 114 | p-value | ||||
Medication class | ||||||||
Not prescription | 5 (4) | 9 (8) | 0.289 | 13 (12) | 10 (8) | 0.453 | 0.084 | 0.984 |
Antihypertensives | 94 (83) | 98 (86) | 0.289 | 94 (83) | 99 (88) | 0.063 | 0.743 | 0.845 |
Antidiabetic | 29 (26) | 30 (27) | 1.000 | 31 (28) | 34 (31) | 0.508 | 0.388 | 0.558 |
Antidepressive agents | 27 (24) | 25 (22) | 0.880 | 34 (30) | 29 (26) | 0.533 | 0.322 | 0.536 |
Other cardiovascular drugs | 36 (32) | 40 (35) | 0.481 | 45 (40) | 5 (40) | 1.000 | 0.090 | 0.095 |
Pulmonary | 5 (5) | 6 (5) | 1.000 | 6 (6) | 7 (6) | 1.000 | 0.769 | 0.784 |
Hypolipidemic agents | 36 (32) | 40 (35) | 0.503 | 39 (35) | 41 (37) | 0.774 | 0.687 | 0.890 |
Antihypertensive drugs | ||||||||
Diuretics | 49 (44) | 55 (49) | 0.286 | 49 (44) | 59 (53) | 0.052 | 1.000 | 0.592 |
Beta blockers | 31 (27) | 38 (34) | 0.118 | 35 (32) | 39 (36) | 0.424 | 0.342 | 1.000 |
ACE | 66 (58) | 66 (58) | 1.000 | 63 (57) | 63 (57) | 1.000 | 0.704 | 0.789 |
ARBs | 10 (9) | 13 (12) | 0.508 | 17 (16) | 23 (21) | 0.70 | 0.079 | 0.150 |
CCB | 19 (17) | 22 (20) | 0.453 | 15 (14) | 21 (19) | 0.146 | 0.486 | 0.867 |